Biofrontera (BFRI) Notes Payables (2020 - 2024)

Biofrontera's Notes Payables history runs 5 years deep, the most recent figure standing at $296000.0 for Q2 2024.

• On a quarterly basis, Notes Payables changed N/A year-over-year to $296000.0 in Q2 2024; TTM through Jun 2024 was $296000.0, a N/A change from a year earlier, with the FY2023 full-year figure at $3.9 million, up 197.56% from the prior year.
• Notes Payables slipped to $296000.0 in Q2 2024 per BFRI's latest filing, from $2.4 million in the prior quarter.
• Across five years, Notes Payables topped out at $4.2 million in Q3 2022 and bottomed at $269000.0 in Q1 2022.
• The 5-year median for Notes Payables is $1.4 million (2020), against an average of $1.7 million.
• Across the five-year window, Notes Payables slumped 81.66% in 2021 and surged 365.25% in 2022, its largest moves.
• Year by year, Notes Payables stood at $1.5 million in 2020, then slumped by 81.66% to $282000.0 in 2021, then jumped by 365.25% to $1.3 million in 2022, then soared by 197.56% to $3.9 million in 2023, then sank by 92.42% to $296000.0 in 2024.
• Per Business Quant, the three latest BFRI Notes Payables figures stand at $296000.0 (Q2 2024), $2.4 million (Q1 2024), and $3.9 million (Q4 2023).